• 239 Citations
  • 10 h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yota Yasumizu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 239 Citations
  • 10 h-Index
  • 30 Article
  • 2 Comment/debate

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (Nature Communications, (2020), 11, 1, (338), 10.1038/s41467-019-14219-6)

Yasumizu, Y., Rajabi, H., Jin, C., Hata, T., Pitroda, S., Long, M. D., Hagiwara, M., Li, W., Hu, Q., Liu, S., Yamashita, N., Fushimi, A., Kui, L., Samur, M., Yamamoto, M., Zhang, Y., Zhang, N., Hong, D., Maeda, T., Kosaka, T. & 3 others, Wong, K. K., Oya, M. & Kufe, D., 2020 Dec 1, In : Nature communications. 11, 1, 1095.

Research output: Contribution to journalComment/debate

Open Access
  • MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

    Yasumizu, Y., Rajabi, H., Jin, C., Hata, T., Pitroda, S., Long, M. D., Hagiwara, M., Li, W., Hu, Q., Liu, S., Yamashita, N., Fushimi, A., Kui, L., Samur, M., Yamamoto, M., Zhang, Y., Zhang, N., Hong, D., Maeda, T., Kosaka, T. & 3 others, Wong, K. K., Oya, M. & Kufe, D., 2020 Dec 1, In : Nature communications. 11, 1, 338.

    Research output: Contribution to journalArticle

    Open Access
  • Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells (Oncogene, (2019), 38, 47, (7266-7277), 10.1038/s41388-019-0940-1)

    Rajabi, H., Hata, T., Li, W., Long, M. D., Hu, Q., Liu, S., Raina, D., Kui, L., Yasumizu, Y., Hong, D., Samur, M. & Kufe, D., 2019 Nov 21, In : Oncogene. 38, 47, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

    Ito, K., Masunaga, A., Tanaka, N., Mizuno, R., Shirotake, S., Yasumizu, Y., Ito, Y., Miyazaki, Y., Hagiwara, M., Kanao, K., Mikami, S., Momma, T., Masuda, T., Nakagawa, K., Oyama, M., Asano, T. & Oya, M., 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 69-76 8 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    MUC1-C activates the NuRD complex to drive dedifferentiation of triple-negative breast cancer cells

    Hata, T., Rajabi, H., Takahashi, H., Yasumizu, Y., Li, W., Jin, C., Long, M. D., Hu, Q., Liu, S., Fushimi, A., Yamashita, N., Kui, L., Hong, D., Yamamoto, M., Miyo, M., Hiraki, M., Maeda, T., Suzuki, Y., Samur, M. K. & Kufe, D., 2019 Jan 1, In : Cancer Research. 79, 22, p. 5711-5722 12 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)